ELAEXIA · FITC

Elective Labelling of Exosomes for Identification and Analysis

 

  • Designed for detection by flow cytometry and stringently developed to generate a specific, clear signal without false-positive background
  • Precise and specific binding to exosome bilayer membrane
  • Novel technology, independent of highly variable protein markers which identify exosome subpopulations
  • Direct labelling of exosomes in cell culture supernatant and plasma
  • Compatible with antibody co-staining and multiparametric analysis
  • Fast and Easy-to-use labelling protocol

Oncosomes

Exosomes from breast cancer cells

ELAEXIA · FITC stains exosomes from cell culture supernatant of MCF-7 breast cancer cells (left panel). 1 % Triton treatment leads to destruction/solubilization of exosomes, subsequently no binding occurs (negative control; right panel).

Sample dilution 1:100

Virosomes

Exosomes with SARS-COV-2 Spike Protein

HEK 293T cells were engineered to produce exosomes carrying the Spike 1 Protein of the SARS-CoV-2 virus detected by ELAEXIA·FITC. 1 % Triton treatment leads to destruction/solubilization of exosomes, subsequently no binding occurs (negative control; right panel).

Sample dilution 1:100.

For research use only!